Apart from clinicopathological characteristics, several genic features (such as BRAF, TERT, and RET) can be applied for risk stratification and prognostic scoring systems of thyroid cancer patients (Xing et al., 2005; Lee et al., 2007; Kim et al., 2012). Here, RET is linked to thyroid gland carcinoma.